The Association of Rheumatology Professionals (ARP) has developed programming highlighting the perspectives of ...

Patients with autoimmune inflammatory rheumatic diseases (AIRDs) have a significantly higher risk of developing Long COVID after SARS-CoV-2 infection than patients without AIRDs, according to results ...

A Department of Health and Human Services draft federal policy said that 6 unapproved peptides could soon be sold by compounding pharmacies.

Patients with osteoarthritis support an expanded role for community pharmacists in providing medication advice and exercise counseling.

In patients with rheumatoid arthritis, baseline frailty and prefrailty are linked to a significantly increased risk for incident cancer.

Among adults aged 18 to 64 years old, living alone was associated with an increased risk for death from multiple causes.

SGLT2 inhibitors significantly reduced mortality and lowered risks for cardiovascular and kidney events in CKD patients 80 years and older.

Increased CD4+ and CD8+ T-cell density in salivary gland tissue is evident in patients with Sjögren syndrome prior to measurable salivary dysfunction.

Deucravacitinib treatment yields sustained improvements in joint symptoms and skin disease severity among patients with active psoriatic arthritis.

Patients with interstitial lung disease and an underlying autoimmune condition demonstrate a lower mortality risk than those with idiopathic disease.

Digital physical activity programs for inflammatory arthritis are linked to slight pain reductions but worsening functional disability.

Reducing doses of biologic and targeted synthetic DMARDs effectively maintains low disease activity in patients with rheumatoid arthritis.